Skip to main content
. 2023 Apr 6;6:100200. doi: 10.1016/j.jtauto.2023.100200

Fig. 1.

Fig. 1

SARS-Cov2 memory T cell and humoral responses in patients with systemic lupus erythematosus (SLE) and controls (Cont) following post-COVID19 vaccine or infection. A/E: Anti-Spike cellular and humoral post-vaccine responses in Cont (n = 64) and SLE patients (n = 34). B/F: Anti-Spike memory T cell and humoral post-infection responses in Cont (n = 51) and SLE patients (n = 13). C/G: Anti-Nucleocapsid (Nuc) memory T cell and humoral post-infection responses in Cont and SLE patients. D: Concordance assessment using the Cohen's Kappa coefficient between cellular and humoral assays against Spike and Nuc in Cont and SLE patients. As an example, cross-tabulation between T cell and humoral anti-Spike responses in SLE patients. P values and assay thresholds (dot line) are indicated.